v3.26.3
Description of Business and Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 20, 2026
Jul. 22, 2026
Sep. 12, 2025
USD ($)
$ / shares
shares
Sep. 30, 2026
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
Segment
$ / shares
shares
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Subsidiary, Sale of Stock [Line Items]                        
Research and development expense                       $ 2,983,773
Reverse stock split, description 1-for-20 a 1-for-20 Reverse Stock Split of the Company’s issued and outstanding common stock, which became effective on August 20, 2026. At the effective time, every 20 shares of common stock were automatically converted into one share, with fractional shares rounded up to the nearest whole share. The Reverse Stock Split was effected to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq.               1-for-20    
Net loss       $ 2,815,597 $ 3,290,970 $ 3,150,228 $ 954,059 $ 60,346 $ 137,583 $ 9,256,795 $ 1,151,988  
Cas in operating activities                   3,393,445 9,627,048  
Cash and cash equivalents       1,579,689           1,579,689    
Accumulated deficit       14,104,350           14,104,350   4,847,555
Prepaid research and development       314,783           314,783   $ 6,166,294
Prepaid R&D balance       265,682           265,682    
FDIC insured amount       $ 250,000           $ 250,000    
Common stock, par value | $ / shares       $ 0.0001           $ 0.0001   $ 0.0001
Net proceeds                   $ 15,655,192  
Number of operating segment | Segment                   1    
Number of reportable segment | Segment                   1    
IPO [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued, shares | shares                   187,500    
Common stock, par value | $ / shares       0.0001           $ 0.0001    
Sale of stock price per share | $ / shares       $ 80.00           $ 80.00    
Gross proceeds                   $ 15,000,000.0    
Net proceeds                   2,120,000    
Underwriting discounts and commissions                   1,410,000    
Other offering related expenses       $ 710,000           710,000    
Net proceeds                   $ 13,240,000    
Over-Allotment Option [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares issued, shares | shares     28,125                  
Sale of stock price per share | $ / shares     $ 80.00                  
Gross proceeds     $ 2,250,000                  
Underwriting discounts and commissions     180,000                  
Net proceeds     $ 2,070,000.00